Paper11222367
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.
Thomis DC and 6 others. Blood, 2001. Cited by 163 papers, by iCite.
Cite this record
ConductScience Library. A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease. Papers, record 11222367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11222367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graft vs Host Disease | Major topic |
| T-Lymphocytes | Major topic |
| fas Receptor | Major topic |
| Apoptosis | |
| Bone Marrow Transplantation | |
| Cross-Linking Reagents | |
| Dose-Response Relationship, Drug | |
| Gene Rearrangement | |
| Humans | |
| Immunomagnetic Separation | |
| Lymphocyte Activation | |
| Organic Chemicals | |
| Recombinant Fusion Proteins | |
| Retroviridae | |
| Tacrolimus Binding Proteins | |
| Time Factors | |
| Transduction, Genetic | |
| Transgenes |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TGT06S01 | Telethon | Italy | PubMed |
Source PubMed
Cited by66
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40770153 | CAR T-cell immunotherapy as the next horizon in cancer eradication: current landscape, challenges, and future directions. | Med Oncol | 2025 | https://conductscience.org/library/papers/40770153 | PubMed |
| 39674824 | Evolving strategies for addressing CAR T-cell toxicities. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/39674824 | PubMed |
| 38584391 | Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy. | Mol Ther | 2024 | https://conductscience.org/library/papers/38584391 | PubMed |
| 37173999 | Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37173999 | PubMed |
| 37158883 | CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37158883 | PubMed |
| 36922828 | Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility. | J Transl Med | 2023 | https://conductscience.org/library/papers/36922828 | PubMed |
| 36463361 | SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity. | Sci Rep | 2022 | https://conductscience.org/library/papers/36463361 | PubMed |
| 34948123 | Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34948123 | PubMed |
| 34841295 | Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy. | Cell Rep Med | 2021 | https://conductscience.org/library/papers/34841295 | PubMed |
| 34638227 | Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638227 | PubMed |
| 34412685 | Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/34412685 | PubMed |
| 33919245 | Pharmacologic Control of CAR T Cells. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33919245 | PubMed |
| 33869011 | Strategies for Dodging the Obstacles in CAR T Cell Therapy. | Front Oncol | 2021 | https://conductscience.org/library/papers/33869011 | PubMed |
| 33329526 | Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas. | Front Immunol | 2020 | https://conductscience.org/library/papers/33329526 | PubMed |
| 33013822 | TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals. | Front Immunol | 2020 | https://conductscience.org/library/papers/33013822 | PubMed |
| 32498368 | Anti-PSMA CAR-engineered NK-92 Cells: An Off-the-shelf Cell Therapy for Prostate Cancer. | Cells | 2020 | https://conductscience.org/library/papers/32498368 | PubMed |
| 31723811 | CAR T Cells: A Snapshot on the Growing Options to Design a CAR. | Hemasphere | 2019 | https://conductscience.org/library/papers/31723811 | PubMed |
| 30892136 | Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells. | MAbs | 2019 | https://conductscience.org/library/papers/30892136 | PubMed |
| 30796733 | Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors. | Drugs | 2019 | https://conductscience.org/library/papers/30796733 | PubMed |
| 29728788 | Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice. | Med Oncol | 2018 | https://conductscience.org/library/papers/29728788 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11222367
GET https://conductscience.org/api/papers/v1/11222367/cited_by?page=2